ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Ranok Therapeutics Announces Agreement with Pfizer on Targeted Protein Degradation AmericanPharmaceuticalReview
December 02, 2021Ranok Therapeutics (Hangzhou) Co. Ltd., an emerging biopharmaceutical company focused on developing breakthrough therapies for cancer and other serious diseases, today announced an agreement with Pfizer Inc. to apply and evaluate Ranok’s CHAMP? platfor... -
CRISPR and MaxCyte sign licensing deal for cancer therapies
pharmaceutical-technology
November 13, 2018Swiss gene editing firm CRISPR Therapeutics has signed a non-exclusive commercial licence agreement with US-based drug maker MaxCyte for the development of new immuno-oncology therapies. -
Race and TargImmune to develop new cancer therapies
pharmaceutical-technology
July 12, 2017Australian-based specialist pharmaceutical firm Race Oncology has executed a Letter of Intent (LoI) with Swiss-based biotechnology TargImmune Therapeutics to enter a joint venture (JV) between the two companies to develop new and improved cancer therapies
Pharma Sources Insight January 2025
